Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells

V. Kozlova, A. Ledererova, A. Ladungova, H. Peschelova, P. Janovska, A. Slusarczyk, J. Domagala, P. Kopcil, V. Vakulova, J. Oppelt, V. Bryja, M. Doubek, J. Mayer, S. Pospisilova, M. Smida,

. 2020 ; 15 (3) : e0229170. [pub] 20200325

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20023098

Surface protein CD20 serves as the critical target of immunotherapy in various B-cell malignancies for decades, however its biological function and regulation remain largely elusive. Better understanding of CD20 function may help to design improved rational therapies to prevent development of resistance. Using CRISPR/Cas9 technique, we have abrogated CD20 expression in five different malignant B-cell lines. We show that CD20 deletion has no effect upon B-cell receptor signaling or calcium flux. Also B-cell survival and proliferation is unaffected in the absence of CD20. On the contrary, we found a strong defect in actin cytoskeleton polymerization and, consequently, defective cell adhesion and migration in response to homeostatic chemokines SDF1α, CCL19 and CCL21. Mechanistically, we could identify a reduction in chemokine-triggered PYK2 activation, a calcium-activated signaling protein involved in activation of MAP kinases and cytoskeleton regulation. These cellular defects in consequence result in a severely disturbed homing of B cells in vivo.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023098
003      
CZ-PrNML
005      
20201214125253.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0229170 $2 doi
035    __
$a (PubMed)32210425
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kozlova, Veronika $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
245    10
$a CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells / $c V. Kozlova, A. Ledererova, A. Ladungova, H. Peschelova, P. Janovska, A. Slusarczyk, J. Domagala, P. Kopcil, V. Vakulova, J. Oppelt, V. Bryja, M. Doubek, J. Mayer, S. Pospisilova, M. Smida,
520    9_
$a Surface protein CD20 serves as the critical target of immunotherapy in various B-cell malignancies for decades, however its biological function and regulation remain largely elusive. Better understanding of CD20 function may help to design improved rational therapies to prevent development of resistance. Using CRISPR/Cas9 technique, we have abrogated CD20 expression in five different malignant B-cell lines. We show that CD20 deletion has no effect upon B-cell receptor signaling or calcium flux. Also B-cell survival and proliferation is unaffected in the absence of CD20. On the contrary, we found a strong defect in actin cytoskeleton polymerization and, consequently, defective cell adhesion and migration in response to homeostatic chemokines SDF1α, CCL19 and CCL21. Mechanistically, we could identify a reduction in chemokine-triggered PYK2 activation, a calcium-activated signaling protein involved in activation of MAP kinases and cytoskeleton regulation. These cellular defects in consequence result in a severely disturbed homing of B cells in vivo.
650    _2
$a aktiny $x metabolismus $7 D000199
650    _2
$a zvířata $7 D000818
650    _2
$a antigeny CD20 $x genetika $x metabolismus $x fyziologie $7 D018951
650    _2
$a B-lymfocyty $x patologie $x fyziologie $7 D001402
650    _2
$a buněčná adheze $x fyziologie $7 D002448
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a pohyb buněk $x fyziologie $7 D002465
650    _2
$a genový knockdown $7 D055785
650    _2
$a lidé $7 D006801
650    _2
$a leukemie B-buněčná $x metabolismus $x patologie $7 D015448
650    _2
$a B-buněčný lymfom $x metabolismus $x patologie $7 D016393
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a myši SCID $7 D016513
650    _2
$a myši transgenní $7 D008822
650    _2
$a polymerizace $7 D058105
650    _2
$a multimerizace proteinu $x fyziologie $7 D055503
650    _2
$a receptory antigenů B-buněk $x metabolismus $7 D011947
650    _2
$a signální transdukce $x imunologie $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ledererova, Aneta $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Ladungova, Adriana $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
700    1_
$a Peschelova, Helena $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
700    1_
$a Janovska, Pavlina $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Slusarczyk, Aleksander $u Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
700    1_
$a Domagala, Joanna $u Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
700    1_
$a Kopcil, Pavel $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
700    1_
$a Vakulova, Viera $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
700    1_
$a Oppelt, Jan $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
700    1_
$a Bryja, Vitezslav $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Doubek, Michael $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Mayer, Jiri $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Pospisilova, Sarka $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Smida, Michal $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 15, č. 3 (2020), s. e0229170
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32210425 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125252 $b ABA008
999    __
$a ok $b bmc $g 1595417 $s 1113774
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 15 $c 3 $d e0229170 $e 20200325 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options